ID SCML2_HUMAN Reviewed; 700 AA. AC Q9UQR0; Q5JXE6; Q86U98; Q8IWD0; Q8NDP2; Q9UGC5; DT 10-MAY-2004, integrated into UniProtKB/Swiss-Prot. DT 01-MAY-2000, sequence version 1. DT 24-JAN-2024, entry version 190. DE RecName: Full=Sex comb on midleg-like protein 2; GN Name=SCML2; OS Homo sapiens (Human). OC Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia; OC Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae; OC Homo. OX NCBI_TaxID=9606; RN [1] RP NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), AND TISSUE SPECIFICITY. RX PubMed=10331946; DOI=10.1006/geno.1999.5755; RA Montini E., Buchner G., Spalluto C., Andolfi G., Caruso A., de Dunnen J.T., RA Trump D., Rocchi M., Ballabio A., Franco B.; RT "Identification of SCML2, a second human gene homologous to the Drosophila RT Sex comb on midleg (Scm): a new gene cluster on Xp22."; RL Genomics 58:65-72(1999). RN [2] RP NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2). RC TISSUE=Testis; RX PubMed=17974005; DOI=10.1186/1471-2164-8-399; RA Bechtel S., Rosenfelder H., Duda A., Schmidt C.P., Ernst U., RA Wellenreuther R., Mehrle A., Schuster C., Bahr A., Bloecker H., Heubner D., RA Hoerlein A., Michel G., Wedler H., Koehrer K., Ottenwaelder B., Poustka A., RA Wiemann S., Schupp I.; RT "The full-ORF clone resource of the German cDNA consortium."; RL BMC Genomics 8:399-399(2007). RN [3] RP NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]. RX PubMed=15772651; DOI=10.1038/nature03440; RA Ross M.T., Grafham D.V., Coffey A.J., Scherer S., McLay K., Muzny D., RA Platzer M., Howell G.R., Burrows C., Bird C.P., Frankish A., Lovell F.L., RA Howe K.L., Ashurst J.L., Fulton R.S., Sudbrak R., Wen G., Jones M.C., RA Hurles M.E., Andrews T.D., Scott C.E., Searle S., Ramser J., Whittaker A., RA Deadman R., Carter N.P., Hunt S.E., Chen R., Cree A., Gunaratne P., RA Havlak P., Hodgson A., Metzker M.L., Richards S., Scott G., Steffen D., RA Sodergren E., Wheeler D.A., Worley K.C., Ainscough R., Ambrose K.D., RA Ansari-Lari M.A., Aradhya S., Ashwell R.I., Babbage A.K., Bagguley C.L., RA Ballabio A., Banerjee R., Barker G.E., Barlow K.F., Barrett I.P., RA Bates K.N., Beare D.M., Beasley H., Beasley O., Beck A., Bethel G., RA Blechschmidt K., Brady N., Bray-Allen S., Bridgeman A.M., Brown A.J., RA Brown M.J., Bonnin D., Bruford E.A., Buhay C., Burch P., Burford D., RA Burgess J., Burrill W., Burton J., Bye J.M., Carder C., Carrel L., RA Chako J., Chapman J.C., Chavez D., Chen E., Chen G., Chen Y., Chen Z., RA Chinault C., Ciccodicola A., Clark S.Y., Clarke G., Clee C.M., Clegg S., RA Clerc-Blankenburg K., Clifford K., Cobley V., Cole C.G., Conquer J.S., RA Corby N., Connor R.E., David R., Davies J., Davis C., Davis J., Delgado O., RA Deshazo D., Dhami P., Ding Y., Dinh H., Dodsworth S., Draper H., RA Dugan-Rocha S., Dunham A., Dunn M., Durbin K.J., Dutta I., Eades T., RA Ellwood M., Emery-Cohen A., Errington H., Evans K.L., Faulkner L., RA Francis F., Frankland J., Fraser A.E., Galgoczy P., Gilbert J., Gill R., RA Gloeckner G., Gregory S.G., Gribble S., Griffiths C., Grocock R., Gu Y., RA Gwilliam R., Hamilton C., Hart E.A., Hawes A., Heath P.D., Heitmann K., RA Hennig S., Hernandez J., Hinzmann B., Ho S., Hoffs M., Howden P.J., RA Huckle E.J., Hume J., Hunt P.J., Hunt A.R., Isherwood J., Jacob L., RA Johnson D., Jones S., de Jong P.J., Joseph S.S., Keenan S., Kelly S., RA Kershaw J.K., Khan Z., Kioschis P., Klages S., Knights A.J., Kosiura A., RA Kovar-Smith C., Laird G.K., Langford C., Lawlor S., Leversha M., Lewis L., RA Liu W., Lloyd C., Lloyd D.M., Loulseged H., Loveland J.E., Lovell J.D., RA Lozado R., Lu J., Lyne R., Ma J., Maheshwari M., Matthews L.H., RA McDowall J., McLaren S., McMurray A., Meidl P., Meitinger T., Milne S., RA Miner G., Mistry S.L., Morgan M., Morris S., Mueller I., Mullikin J.C., RA Nguyen N., Nordsiek G., Nyakatura G., O'dell C.N., Okwuonu G., Palmer S., RA Pandian R., Parker D., Parrish J., Pasternak S., Patel D., Pearce A.V., RA Pearson D.M., Pelan S.E., Perez L., Porter K.M., Ramsey Y., Reichwald K., RA Rhodes S., Ridler K.A., Schlessinger D., Schueler M.G., Sehra H.K., RA Shaw-Smith C., Shen H., Sheridan E.M., Shownkeen R., Skuce C.D., RA Smith M.L., Sotheran E.C., Steingruber H.E., Steward C.A., Storey R., RA Swann R.M., Swarbreck D., Tabor P.E., Taudien S., Taylor T., Teague B., RA Thomas K., Thorpe A., Timms K., Tracey A., Trevanion S., Tromans A.C., RA d'Urso M., Verduzco D., Villasana D., Waldron L., Wall M., Wang Q., RA Warren J., Warry G.L., Wei X., West A., Whitehead S.L., Whiteley M.N., RA Wilkinson J.E., Willey D.L., Williams G., Williams L., Williamson A., RA Williamson H., Wilming L., Woodmansey R.L., Wray P.W., Yen J., Zhang J., RA Zhou J., Zoghbi H., Zorilla S., Buck D., Reinhardt R., Poustka A., RA Rosenthal A., Lehrach H., Meindl A., Minx P.J., Hillier L.W., Willard H.F., RA Wilson R.K., Waterston R.H., Rice C.M., Vaudin M., Coulson A., Nelson D.L., RA Weinstock G., Sulston J.E., Durbin R.M., Hubbard T., Gibbs R.A., Beck S., RA Rogers J., Bentley D.R.; RT "The DNA sequence of the human X chromosome."; RL Nature 434:325-337(2005). RN [4] RP NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]. RA Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L., Mobarry C.M., RA Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J., RA Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S., RA Turner R., Yooseph S., Lu F., Nusskern D.R., Shue B.C., Zheng X.H., RA Zhong F., Delcher A.L., Huson D.H., Kravitz S.A., Mouchard L., Reinert K., RA Remington K.A., Clark A.G., Waterman M.S., Eichler E.E., Adams M.D., RA Hunkapiller M.W., Myers E.W., Venter J.C.; RL Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases. RN [5] RP NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1). RC TISSUE=Testis, and Uterus; RX PubMed=15489334; DOI=10.1101/gr.2596504; RG The MGC Project Team; RT "The status, quality, and expansion of the NIH full-length cDNA project: RT the Mammalian Gene Collection (MGC)."; RL Genome Res. 14:2121-2127(2004). RN [6] RP IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]. RC TISSUE=Embryonic kidney; RX PubMed=17525332; DOI=10.1126/science.1140321; RA Matsuoka S., Ballif B.A., Smogorzewska A., McDonald E.R. III, Hurov K.E., RA Luo J., Bakalarski C.E., Zhao Z., Solimini N., Lerenthal Y., Shiloh Y., RA Gygi S.P., Elledge S.J.; RT "ATM and ATR substrate analysis reveals extensive protein networks RT responsive to DNA damage."; RL Science 316:1160-1166(2007). RN [7] RP PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-256; SER-267; SER-299; RP SER-300; THR-305; SER-499; THR-503; SER-511; SER-583; SER-590 AND SER-594, RP AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]. RC TISSUE=Cervix carcinoma; RX PubMed=18669648; DOI=10.1073/pnas.0805139105; RA Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E., RA Elledge S.J., Gygi S.P.; RT "A quantitative atlas of mitotic phosphorylation."; RL Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008). RN [8] RP IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]. RX PubMed=19413330; DOI=10.1021/ac9004309; RA Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J., Mohammed S.; RT "Lys-N and trypsin cover complementary parts of the phosphoproteome in a RT refined SCX-based approach."; RL Anal. Chem. 81:4493-4501(2009). RN [9] RP PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-499; SER-511 AND SER-590, AND RP IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]. RC TISSUE=Leukemic T-cell; RX PubMed=19690332; DOI=10.1126/scisignal.2000007; RA Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K., RA Rodionov V., Han D.K.; RT "Quantitative phosphoproteomic analysis of T cell receptor signaling RT reveals system-wide modulation of protein-protein interactions."; RL Sci. Signal. 2:RA46-RA46(2009). RN [10] RP PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-499; THR-503; SER-511 AND RP SER-590, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]. RC TISSUE=Cervix carcinoma; RX PubMed=20068231; DOI=10.1126/scisignal.2000475; RA Olsen J.V., Vermeulen M., Santamaria A., Kumar C., Miller M.L., RA Jensen L.J., Gnad F., Cox J., Jensen T.S., Nigg E.A., Brunak S., Mann M.; RT "Quantitative phosphoproteomics reveals widespread full phosphorylation RT site occupancy during mitosis."; RL Sci. Signal. 3:RA3-RA3(2010). RN [11] RP IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]. RX PubMed=21269460; DOI=10.1186/1752-0509-5-17; RA Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P., Buerckstuemmer T., RA Bennett K.L., Superti-Furga G., Colinge J.; RT "Initial characterization of the human central proteome."; RL BMC Syst. Biol. 5:17-17(2011). RN [12] RP PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-499; SER-511 AND SER-590, AND RP IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]. RX PubMed=21406692; DOI=10.1126/scisignal.2001570; RA Rigbolt K.T., Prokhorova T.A., Akimov V., Henningsen J., Johansen P.T., RA Kratchmarova I., Kassem M., Mann M., Olsen J.V., Blagoev B.; RT "System-wide temporal characterization of the proteome and phosphoproteome RT of human embryonic stem cell differentiation."; RL Sci. Signal. 4:RS3-RS3(2011). RN [13] RP PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-256; SER-261; SER-267; RP SER-499; SER-511; SER-522; SER-570; SER-583 AND SER-590, AND IDENTIFICATION RP BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]. RC TISSUE=Cervix carcinoma, and Erythroleukemia; RX PubMed=23186163; DOI=10.1021/pr300630k; RA Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J., RA Mohammed S.; RT "Toward a comprehensive characterization of a human cancer cell RT phosphoproteome."; RL J. Proteome Res. 12:260-271(2013). RN [14] RP PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-590, AND IDENTIFICATION BY RP MASS SPECTROMETRY [LARGE SCALE ANALYSIS]. RC TISSUE=Liver; RX PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014; RA Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D., Wang L., RA Ye M., Zou H.; RT "An enzyme assisted RP-RPLC approach for in-depth analysis of human liver RT phosphoproteome."; RL J. Proteomics 96:253-262(2014). RN [15] RP SUMOYLATION [LARGE SCALE ANALYSIS] AT LYS-536, AND IDENTIFICATION BY MASS RP SPECTROMETRY [LARGE SCALE ANALYSIS]. RX PubMed=25218447; DOI=10.1038/nsmb.2890; RA Hendriks I.A., D'Souza R.C., Yang B., Verlaan-de Vries M., Mann M., RA Vertegaal A.C.; RT "Uncovering global SUMOylation signaling networks in a site-specific RT manner."; RL Nat. Struct. Mol. Biol. 21:927-936(2014). RN [16] RP SUMOYLATION [LARGE SCALE ANALYSIS] AT LYS-518; LYS-536; LYS-599 AND RP LYS-605, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]. RX PubMed=28112733; DOI=10.1038/nsmb.3366; RA Hendriks I.A., Lyon D., Young C., Jensen L.J., Vertegaal A.C., RA Nielsen M.L.; RT "Site-specific mapping of the human SUMO proteome reveals co-modification RT with phosphorylation."; RL Nat. Struct. Mol. Biol. 24:325-336(2017). RN [17] RP X-RAY CRYSTALLOGRAPHY (1.78 ANGSTROMS) OF 33-243. RX PubMed=12952983; DOI=10.1074/jbc.m306469200; RA Sathyamurthy A., Allen M.D., Murzin A.G., Bycroft M.; RT "Crystal structure of the malignant brain tumor (MBT) repeats in sex comb RT on midleg-like 2 (SCML2)."; RL J. Biol. Chem. 278:46968-46973(2003). CC -!- FUNCTION: Putative Polycomb group (PcG) protein. PcG proteins act by CC forming multiprotein complexes, which are required to maintain the CC transcriptionally repressive state of homeotic genes throughout CC development (By similarity). {ECO:0000250}. CC -!- INTERACTION: CC Q9UQR0; Q9H9S4: CAB39L; NbExp=3; IntAct=EBI-2513111, EBI-1047244; CC Q9UQR0; P24941: CDK2; NbExp=3; IntAct=EBI-2513111, EBI-375096; CC Q9UQR0; Q8TBB1: LNX1; NbExp=3; IntAct=EBI-2513111, EBI-739832; CC Q9UQR0; O43639: NCK2; NbExp=3; IntAct=EBI-2513111, EBI-713635; CC Q9UQR0; P78317: RNF4; NbExp=3; IntAct=EBI-2513111, EBI-2340927; CC Q9UQR0; Q5VUG0: SFMBT2; NbExp=3; IntAct=EBI-2513111, EBI-12025260; CC Q9UQR0; A0A286YEY3: SRGAP2B; NbExp=3; IntAct=EBI-2513111, EBI-17766455; CC Q9UQR0-1; P24941: CDK2; NbExp=7; IntAct=EBI-16087037, EBI-375096; CC Q9UQR0-1; P38936: CDKN1A; NbExp=3; IntAct=EBI-16087037, EBI-375077; CC Q9UQR0-1; P46527: CDKN1B; NbExp=2; IntAct=EBI-16087037, EBI-519280; CC -!- SUBCELLULAR LOCATION: Nucleus {ECO:0000305}. CC -!- ALTERNATIVE PRODUCTS: CC Event=Alternative splicing; Named isoforms=2; CC Name=1; CC IsoId=Q9UQR0-1; Sequence=Displayed; CC Name=2; CC IsoId=Q9UQR0-2; Sequence=VSP_010277; CC -!- TISSUE SPECIFICITY: Highly expressed in placenta, thymus and testis. CC Detected at lower levels in brain, liver, skeletal muscle, pancreas and CC ovary. {ECO:0000269|PubMed:10331946}. CC -!- SIMILARITY: Belongs to the SCM family. {ECO:0000305}. CC -!- SEQUENCE CAUTION: CC Sequence=AAH51913.1; Type=Erroneous initiation; Evidence={ECO:0000305}; CC --------------------------------------------------------------------------- CC Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms CC Distributed under the Creative Commons Attribution (CC BY 4.0) License CC --------------------------------------------------------------------------- DR EMBL; Y18004; CAB38943.1; -; mRNA. DR EMBL; AL833937; CAD38792.1; -; mRNA. DR EMBL; AL096763; -; NOT_ANNOTATED_CDS; Genomic_DNA. DR EMBL; AL031007; -; NOT_ANNOTATED_CDS; Genomic_DNA. DR EMBL; Z93023; -; NOT_ANNOTATED_CDS; Genomic_DNA. DR EMBL; BC040497; -; NOT_ANNOTATED_CDS; mRNA. DR EMBL; CH471074; EAW98937.1; -; Genomic_DNA. DR EMBL; BC051913; AAH51913.1; ALT_INIT; mRNA. DR EMBL; BC064617; AAH64617.1; -; mRNA. DR CCDS; CCDS14185.1; -. [Q9UQR0-1] DR RefSeq; NP_006080.1; NM_006089.2. [Q9UQR0-1] DR RefSeq; XP_016884708.1; XM_017029219.1. [Q9UQR0-1] DR RefSeq; XP_016884709.1; XM_017029220.1. [Q9UQR0-1] DR PDB; 1OI1; X-ray; 1.78 A; A=24-243. DR PDB; 2BIV; X-ray; 1.70 A; A/B/C=1-243. DR PDB; 2MEM; NMR; -; A=354-468. DR PDB; 2VYT; X-ray; 1.90 A; A/B=24-243. DR PDB; 4EDU; X-ray; 2.58 A; A=29-243. DR PDBsum; 1OI1; -. DR PDBsum; 2BIV; -. DR PDBsum; 2MEM; -. DR PDBsum; 2VYT; -. DR PDBsum; 4EDU; -. DR AlphaFoldDB; Q9UQR0; -. DR BMRB; Q9UQR0; -. DR SMR; Q9UQR0; -. DR BioGRID; 115661; 64. DR DIP; DIP-53760N; -. DR IntAct; Q9UQR0; 29. DR MINT; Q9UQR0; -. DR STRING; 9606.ENSP00000251900; -. DR GlyCosmos; Q9UQR0; 2 sites, 1 glycan. DR GlyGen; Q9UQR0; 4 sites, 1 O-linked glycan (4 sites). DR iPTMnet; Q9UQR0; -. DR MetOSite; Q9UQR0; -. DR PhosphoSitePlus; Q9UQR0; -. DR SwissPalm; Q9UQR0; -. DR BioMuta; SCML2; -. DR DMDM; 47117338; -. DR EPD; Q9UQR0; -. DR jPOST; Q9UQR0; -. DR MassIVE; Q9UQR0; -. DR MaxQB; Q9UQR0; -. DR PaxDb; 9606-ENSP00000251900; -. DR PeptideAtlas; Q9UQR0; -. DR ProteomicsDB; 85572; -. [Q9UQR0-1] DR ProteomicsDB; 85573; -. [Q9UQR0-2] DR Pumba; Q9UQR0; -. DR ABCD; Q9UQR0; 11 sequenced antibodies. DR Antibodypedia; 475; 225 antibodies from 28 providers. DR DNASU; 10389; -. DR Ensembl; ENST00000251900.9; ENSP00000251900.4; ENSG00000102098.19. [Q9UQR0-1] DR Ensembl; ENST00000398048.4; ENSP00000381126.4; ENSG00000102098.19. [Q9UQR0-2] DR GeneID; 10389; -. DR KEGG; hsa:10389; -. DR MANE-Select; ENST00000251900.9; ENSP00000251900.4; NM_006089.3; NP_006080.1. DR UCSC; uc004cyl.3; human. [Q9UQR0-1] DR AGR; HGNC:10581; -. DR CTD; 10389; -. DR DisGeNET; 10389; -. DR GeneCards; SCML2; -. DR HGNC; HGNC:10581; SCML2. DR HPA; ENSG00000102098; Tissue enhanced (testis). DR MIM; 300208; gene. DR neXtProt; NX_Q9UQR0; -. DR OpenTargets; ENSG00000102098; -. DR PharmGKB; PA34999; -. DR VEuPathDB; HostDB:ENSG00000102098; -. DR eggNOG; KOG3766; Eukaryota. DR GeneTree; ENSGT00940000159407; -. DR HOGENOM; CLU_015000_1_0_1; -. DR InParanoid; Q9UQR0; -. DR OMA; TEEPICC; -. DR OrthoDB; 2908161at2759; -. DR PhylomeDB; Q9UQR0; -. DR TreeFam; TF106488; -. DR PathwayCommons; Q9UQR0; -. DR SignaLink; Q9UQR0; -. DR BioGRID-ORCS; 10389; 11 hits in 782 CRISPR screens. DR ChiTaRS; SCML2; human. DR EvolutionaryTrace; Q9UQR0; -. DR GenomeRNAi; 10389; -. DR Pharos; Q9UQR0; Tbio. DR PRO; PR:Q9UQR0; -. DR Proteomes; UP000005640; Chromosome X. DR RNAct; Q9UQR0; Protein. DR Bgee; ENSG00000102098; Expressed in diaphragm and 177 other cell types or tissues. DR ExpressionAtlas; Q9UQR0; baseline and differential. DR GO; GO:0005634; C:nucleus; IDA:UniProtKB. DR GO; GO:0031519; C:PcG protein complex; IDA:UniProtKB. DR GO; GO:0003682; F:chromatin binding; IBA:GO_Central. DR GO; GO:0042393; F:histone binding; IBA:GO_Central. DR GO; GO:0009653; P:anatomical structure morphogenesis; IMP:GO_Central. DR GO; GO:0045892; P:negative regulation of DNA-templated transcription; IBA:GO_Central. DR CDD; cd20109; MBT_SCML2_rpt2; 1. DR CDD; cd09578; SAM_Scm; 1. DR Gene3D; 2.30.30.140; -; 2. DR Gene3D; 3.90.1150.190; SLED domain; 1. DR Gene3D; 1.10.150.50; Transcription Factor, Ets-1; 1. DR InterPro; IPR004092; Mbt. DR InterPro; IPR001660; SAM. DR InterPro; IPR013761; SAM/pointed_sf. DR InterPro; IPR047531; SAM_Scm-like. DR InterPro; IPR033763; SCML2_RBR. DR InterPro; IPR021987; SLED. DR InterPro; IPR038348; SLED_sf. DR PANTHER; PTHR12247; POLYCOMB GROUP PROTEIN; 1. DR PANTHER; PTHR12247:SF84; SEX COMB ON MIDLEG-LIKE PROTEIN 2; 1. DR Pfam; PF02820; MBT; 2. DR Pfam; PF17208; RBR; 1. DR Pfam; PF00536; SAM_1; 1. DR Pfam; PF12140; SLED; 1. DR SMART; SM00561; MBT; 2. DR SMART; SM00454; SAM; 1. DR SUPFAM; SSF47769; SAM/Pointed domain; 1. DR SUPFAM; SSF63748; Tudor/PWWP/MBT; 2. DR PROSITE; PS51079; MBT; 2. DR Genevisible; Q9UQR0; HS. PE 1: Evidence at protein level; KW 3D-structure; Alternative splicing; Isopeptide bond; Nucleus; KW Phosphoprotein; Reference proteome; Repeat; Repressor; Transcription; KW Transcription regulation; Ubl conjugation. FT CHAIN 1..700 FT /note="Sex comb on midleg-like protein 2" FT /id="PRO_0000097628" FT REPEAT 33..131 FT /note="MBT 1" FT REPEAT 139..240 FT /note="MBT 2" FT DOMAIN 631..700 FT /note="SAM" FT REGION 1..33 FT /note="Disordered" FT /evidence="ECO:0000256|SAM:MobiDB-lite" FT REGION 253..320 FT /note="Disordered" FT /evidence="ECO:0000256|SAM:MobiDB-lite" FT REGION 466..550 FT /note="Disordered" FT /evidence="ECO:0000256|SAM:MobiDB-lite" FT REGION 575..594 FT /note="Disordered" FT /evidence="ECO:0000256|SAM:MobiDB-lite" FT COMPBIAS 253..285 FT /note="Polar residues" FT /evidence="ECO:0000256|SAM:MobiDB-lite" FT COMPBIAS 474..495 FT /note="Basic and acidic residues" FT /evidence="ECO:0000256|SAM:MobiDB-lite" FT COMPBIAS 575..589 FT /note="Polar residues" FT /evidence="ECO:0000256|SAM:MobiDB-lite" FT MOD_RES 256 FT /note="Phosphoserine" FT /evidence="ECO:0007744|PubMed:18669648, FT ECO:0007744|PubMed:23186163" FT MOD_RES 261 FT /note="Phosphoserine" FT /evidence="ECO:0007744|PubMed:23186163" FT MOD_RES 267 FT /note="Phosphoserine" FT /evidence="ECO:0007744|PubMed:18669648, FT ECO:0007744|PubMed:23186163" FT MOD_RES 299 FT /note="Phosphoserine" FT /evidence="ECO:0007744|PubMed:18669648" FT MOD_RES 300 FT /note="Phosphoserine" FT /evidence="ECO:0007744|PubMed:18669648" FT MOD_RES 305 FT /note="Phosphothreonine" FT /evidence="ECO:0007744|PubMed:18669648" FT MOD_RES 499 FT /note="Phosphoserine" FT /evidence="ECO:0007744|PubMed:18669648, FT ECO:0007744|PubMed:19690332, ECO:0007744|PubMed:20068231, FT ECO:0007744|PubMed:21406692, ECO:0007744|PubMed:23186163" FT MOD_RES 503 FT /note="Phosphothreonine" FT /evidence="ECO:0007744|PubMed:18669648, FT ECO:0007744|PubMed:20068231" FT MOD_RES 511 FT /note="Phosphoserine" FT /evidence="ECO:0007744|PubMed:18669648, FT ECO:0007744|PubMed:19690332, ECO:0007744|PubMed:20068231, FT ECO:0007744|PubMed:21406692, ECO:0007744|PubMed:23186163" FT MOD_RES 522 FT /note="Phosphoserine" FT /evidence="ECO:0007744|PubMed:23186163" FT MOD_RES 570 FT /note="Phosphoserine" FT /evidence="ECO:0007744|PubMed:23186163" FT MOD_RES 583 FT /note="Phosphoserine" FT /evidence="ECO:0007744|PubMed:18669648, FT ECO:0007744|PubMed:23186163" FT MOD_RES 590 FT /note="Phosphoserine" FT /evidence="ECO:0007744|PubMed:18669648, FT ECO:0007744|PubMed:19690332, ECO:0007744|PubMed:20068231, FT ECO:0007744|PubMed:21406692, ECO:0007744|PubMed:23186163, FT ECO:0007744|PubMed:24275569" FT MOD_RES 594 FT /note="Phosphoserine" FT /evidence="ECO:0007744|PubMed:18669648" FT CROSSLNK 518 FT /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with FT G-Cter in SUMO2)" FT /evidence="ECO:0007744|PubMed:28112733" FT CROSSLNK 536 FT /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with FT G-Cter in SUMO2)" FT /evidence="ECO:0007744|PubMed:25218447, FT ECO:0007744|PubMed:28112733" FT CROSSLNK 599 FT /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with FT G-Cter in SUMO2)" FT /evidence="ECO:0007744|PubMed:28112733" FT CROSSLNK 605 FT /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with FT G-Cter in SUMO2)" FT /evidence="ECO:0007744|PubMed:28112733" FT VAR_SEQ 1..562 FT /note="Missing (in isoform 2)" FT /evidence="ECO:0000303|PubMed:17974005" FT /id="VSP_010277" FT HELIX 35..42 FT /evidence="ECO:0007829|PDB:2BIV" FT HELIX 49..51 FT /evidence="ECO:0007829|PDB:2BIV" FT STRAND 52..54 FT /evidence="ECO:0007829|PDB:2BIV" FT STRAND 68..73 FT /evidence="ECO:0007829|PDB:2BIV" FT STRAND 76..89 FT /evidence="ECO:0007829|PDB:2BIV" FT STRAND 92..97 FT /evidence="ECO:0007829|PDB:2BIV" FT STRAND 102..104 FT /evidence="ECO:0007829|PDB:2BIV" FT STRAND 106..109 FT /evidence="ECO:0007829|PDB:2BIV" FT STRAND 115..117 FT /evidence="ECO:0007829|PDB:4EDU" FT HELIX 120..123 FT /evidence="ECO:0007829|PDB:2BIV" FT HELIX 138..140 FT /evidence="ECO:0007829|PDB:2BIV" FT HELIX 141..149 FT /evidence="ECO:0007829|PDB:2BIV" FT HELIX 157..159 FT /evidence="ECO:0007829|PDB:2BIV" FT STRAND 177..181 FT /evidence="ECO:0007829|PDB:2BIV" FT STRAND 189..198 FT /evidence="ECO:0007829|PDB:2BIV" FT STRAND 201..206 FT /evidence="ECO:0007829|PDB:2BIV" FT HELIX 211..213 FT /evidence="ECO:0007829|PDB:2BIV" FT STRAND 215..218 FT /evidence="ECO:0007829|PDB:2BIV" FT HELIX 229..233 FT /evidence="ECO:0007829|PDB:2BIV" FT STRAND 356..359 FT /evidence="ECO:0007829|PDB:2MEM" FT STRAND 369..371 FT /evidence="ECO:0007829|PDB:2MEM" FT HELIX 373..378 FT /evidence="ECO:0007829|PDB:2MEM" FT STRAND 383..387 FT /evidence="ECO:0007829|PDB:2MEM" FT HELIX 388..402 FT /evidence="ECO:0007829|PDB:2MEM" FT HELIX 406..409 FT /evidence="ECO:0007829|PDB:2MEM" FT STRAND 422..427 FT /evidence="ECO:0007829|PDB:2MEM" FT STRAND 430..435 FT /evidence="ECO:0007829|PDB:2MEM" FT HELIX 442..455 FT /evidence="ECO:0007829|PDB:2MEM" SQ SEQUENCE 700 AA; 77257 MW; 05E086D4928DEE73 CRC64; MGQTVNEDSM DVKKENQEKT PQSSTSSVQR DDFHWEEYLK ETGSISAPSE CFRQSQIPPV NDFKVGMKLE ARDPRNATSV CIATVIGITG ARLRLRLDGS DNRNDFWRLV DSPDIQPVGT CEKEGDLLQP PLGYQMNTSS WPMFLLKTLN GSEMASATLF KKEPPKPPLN NFKVGMKLEA IDKKNPYLIC PATIGDVKGD EVHITFDGWS GAFDYWCKYD SRDIFPAGWC RLTGDVLQPP GTSVPIVKNI AKTESSPSEA SQHSMQSPQK TTLILPTQQV RRSSRIKPPG PTAVPKRSSS VKNITPRKKG PNSGKKEKPL PVICSTSAAS LKSLTRDRGM LYKDVASGPC KIVMSTVCVY VNKHGNFGPH LDPKRIQQLP DHFGPGPVNV VLRRIVQACV DCALETKTVF GYLKPDNRGG EVITASFDGE THSIQLPPVN SASFALRFLE NFCHSLQCDN LLSSQPFSSS RGHTHSSAEH DKNQSAKEDV TERQSTKRSP QQTVPYVVPL SPKLPKTKEY ASEGEPLFAG GSAIPKEENL SEDSKSSSLN SGNYLNPACR NPMYIHTSVS QDFSRSVPGT TSSPLVGDIS PKSSPHEVKF QMQRKSEAPS YIAVPDPSVL KQGFSKDPST WSVDEVIQFM KHTDPQISGP LADLFRQHEI DGKALFLLKS DVMMKYMGLK LGPALKLCYY IEKLKEGKYS //